We are live on ! Find out more
DCM

Decatur Capital Management Portfolio holdings

AUM $219M
1-Year Est. Return 36.12%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+36.12%
3 Year Est. Return
+131.91%
5 Year Est. Return
+185.8%
10 Year Est. Return
+862.87%
AUM
$139M
AUM Growth
+$6.65M
Cap. Flow
+$3M
Cap. Flow %
2.16%
Top 10 Hldgs %
44.91%
Holding
61
New
5
Increased
4
Reduced
11
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 40.44%
2 Healthcare 15.92%
3 Consumer Discretionary 11.01%
4 Industrials 7.79%
5 Financials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEEV icon
51
Veeva Systems
VEEV
$37.4B
$1.09M 0.78%
6,740
ADSK icon
52
Autodesk
ADSK
$52.6B
$1.06M 0.76%
5,669
MET icon
53
MetLife
MET
$62.1B
$902K 0.65%
12,465
+69
+0.6% +$4.94K
GM icon
54
General Motors
GM
$76.8B
$867K 0.62%
25,760
VMC icon
55
Vulcan Materials
VMC
$36.9B
$726K 0.52%
4,146
SPY icon
56
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$268K 0.19%
702
-189
-21% -$72.6K
SAN icon
57
Banco Santander
SAN
$210B
$111K 0.08%
+37,500
New +$102K
ERIC icon
58
Ericsson
ERIC
$33.3B
$63K 0.05%
+10,841
New +$65.2K
DIS icon
59
Walt Disney
DIS
$181B
-4,106
Closed -$387K
EFA icon
60
iShares MSCI EAFE ETF
EFA
$80.2B
-5,986
Closed -$335K
MGM icon
61
MGM Resorts International
MGM
$11.2B
-19,361
Closed -$575K

Similar funds

Decatur Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Decatur Capital Management held 61 positions worth $139M, up 5% from $132M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Decatur Capital Management's Q4 2022 filing shows 5 new, 4 increased, 11 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 7,032 shares worth $2.03M. The largest sale was NVIDIA, an estimated $690K.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 42% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Decatur Capital Management's largest Q4 2022 buy was Vertex Pharmaceuticals: 7,032 shares worth $2.03M.
  • Decatur Capital Management added most to MetLife in Q4 2022, an estimated $4.94K increase.
  • Decatur Capital Management's biggest Q4 2022 reduction was NVIDIA, cutting an estimated $690K.
  • Decatur Capital Management fully exited MGM Resorts International in Q4 2022, selling an estimated $575K.
  • Decatur Capital Management's ten largest holdings make up 45% of its $139M portfolio in Q4 2022.
  • Decatur Capital Management opened 5 new positions and closed 3 in Q4 2022.
  • Decatur Capital Management's portfolio value rose 5% quarter-over-quarter to $139M.

Based on Decatur Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.